Skip to main content

Akshay Vaishnaw

Editas Medicine has appointed Akshay Vaishnaw to its board of directors. 

He is Executive VP of R&D and CMO at Alnylam Pharmaceuticals. Vaishnaw received his MD from the University of Wales and a PhD in molecular immunology from the University of London. 

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.